Kalytera Therapeutics is committed to developing new treatments for a variety of diseases and disorders, by discovering, developing, manufacturing and delivering innovative human therapeutics. Kalytera focuses on areas of unmet medical need, and leverages its expertise to find solutions that will improve health outcomes and dramatically improve people’s lives.
Download Corporate Presentation
U.S. and Canadian Legal Counsel
79 Wellington Street West
Toronto, Ontario M5K 1N2 Canada
Ernst & Young LLP
700 West Georgia Street
V7Y 1C7 Vancouver
Research and Development
New Website Coming Soon
© 2020 Kalytera Therapeutics, Inc.
© 2016 Kalytera Therapeutics, Inc.